Skip to content

Clinical study on the treatment of neurogenic bladder retention after spinal cord injury by TCM syndrome differentiation and rehabilitation

Clinical study on the treatment of neurogenic bladder retention after spinal cord injury by TCM syndrome differentiation and rehabilitation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076840
Enrollment
Unknown
Registered
2023-10-20
Start date
2023-10-20
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurogenic bladder retention after spinal cord injury

Interventions

Control group:Conventional rehabilitation
Experimental group:Conventional rehabilitation treatment + TCM syndrome differentiation rehabilitation treatment

Sponsors

Henan Provincial Hospital of Traditional Chinese Medicine(The Second Affiliated Hospital of Henan University of Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) The diagnostic criteria for neurogenic bladder retention after SCISCI were met; (2) Duration of spinal cord injury 100ml; (5) 18 years old = age =70 years old, male and female; (6) Patients who voluntarily participate in the study and sign the "informed consent" by the patient himself or his legal guardia

Exclusion criteria

Exclusion criteria: (1) serious heart, brain, kidney and other important organ diseases; (2) Abnormal urination due to mechanical obstruction of urethral outlet; (3) Patients with severe autonomic hyperreflexia during urination; (4) Those who had undergone surgical treatment such as vesicostomy, anterior urethral sphincter incision, artificial urethral sphincter implantation, sacral nerve and sacral pulp stimulation device implantation; (5) There are serious infected people at the time of examination, with bladder muscle injury; (6) Participants in other clinical trials that affect the evaluation of the results of this study.

Design outcomes

Primary

MeasureTime frame
Residual bladder urine volume;Voluntary urine output;

Secondary

MeasureTime frame
Safe bladder capacity;Bladder safety pressure;MBC;MBP;Urine Flow Rate;Urinary leakage;QOL;

Countries

China

Contacts

Public ContactLi Yanjie

Henan Provincial Hospital of Traditional Chinese Medicine(The Second Affiliated Hospital of Henan University of Chinese Medicine)

yanjieli2008@126.com+86 158 3803 9999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026